Figure 2.

The figure represents the distribution of p-values of the 8,207 markers analyzed in the Phase I study. These p-values were used as guidance to select markers for Phase II.

Feugang et al. BMC Genomics 2009 10:176   doi:10.1186/1471-2164-10-176
Download authors' original image